STAT October 17, 2024
Differing philosophies within and outside of government could doom the hub
Over the summer, the Food and Drug Administration announced the creation of the Rare Disease Innovation Hub to serve as a point of collaboration and connectivity between the Center for Biologics Evaluation and Research (CBER), the Center for Drug Evaluation and Research (CDER), patient organizations, and product innovators with the goal of ultimately improving outcomes for patients. But how can it become more than...
Today's Sponsors
Today's Sponsor